Epoxyeicosatrienoic Acids Function as Selective, Endogenous Antagonists of Native Thromboxane Receptors: Identification of a Novel Mechanism of Vasodilation
- 3 October 2008
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in The Journal of pharmacology and experimental therapeutics
- Vol. 328 (1), 231-239
- https://doi.org/10.1124/jpet.108.145102
Abstract
Epoxy- and dihydroxy-eicosatrienoic acids (EETs and DHETs) are vasoactive cytochrome P450 metabolites of arachidonic acid. Interestingly, however, the mechanism(s) by which EETs/DHETs mediate smooth muscle relaxation remains unclear. In contrast to previous reports, where dilation was purportedly large-conductance Ca2+-activated K+ (BKCa) and/or transient receptor potential cation channel, subfamily V, member 4 (TRPV4) channel-mediated, 14,15-EET-induced vasodilation [reversal of contractile tone established with the thromboxane receptor (TP) agonist 15-hydroxy-11α,9α-(epoxymethano)prosta-5,13-dienoic acid (U-46619)] was unaltered in BKCa and TRPV4 knockout mouse isolated aortae compared with wild-type controls, indicating a significant BKCa/TRPV4-resistant mechanism. Whereas all EET and DHET regioisomers reversed U-46619 contraction in rat aortae and mouse mesenteric resistance arteries, these eicosanoids failed to alter phenylephrine-induced contraction, suggesting that they mediated dilation via a “TP-selective” mechanism. Competitive TP antagonism was also observed in nonvascular tissue, including rat fundus and tertiary bronchus, indicating that the effect is not specific to blood vessels. Such effects were TP-selective because 14,15-EET failed to inhibit “non-TP” prostanoid receptor-mediated function in multiple cell/tissue-based assays (Kb > 10 μM). In accordance, 14,15-EET inhibited specific [3H]7-(3-((2-((phenylamino)carbonyl)hydrazino)-methyl)-7-oxabicyclo(2.2.1)hept-2-yl)-5-heptenoic acid (SQ-29548) binding to human recombinant TP receptor, with a Ki value of 3.2 μM, and it showed weaker affinity for non-TP prostanoid receptors, including DP, FP, EP1–4, and IP receptors (Ki values of 6.1, 5.3, 42.6, 19.7, 13.2, 20.2, and >25 μM, respectively) and no appreciable affinity (Ki values >10 μM) for a diverse array of pharmacologically distinct receptors, including the leukotriene receptors Cys-LT1/2 and BLT1. As such, EETs/DHETs represent a unique class of “endogenous” G protein-coupled receptor competitive antagonists, inducing vasodilation via direct TP inhibition. Thus, EETs/DHETs represent novel autoregulatory agents, directly modulating the actions of cyclooxygenase-derived eicosanoids following arachidonic acid mobilization.Keywords
This publication has 35 references indexed in Scilit:
- CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) studyPharmacogenetics and Genomics, 2007
- Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular systemTrends in Pharmacological Sciences, 2007
- Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile FunctionCirculation Research, 2006
- Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory painLife Sciences, 2006
- GW627368X ((N‐{2‐[4‐(4,9‐diethoxy‐1‐oxo‐1,3‐dihydro‐2H‐benzo[f]isoindol‐2‐yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonistBritish Journal of Pharmacology, 2006
- Genetic variation in soluble epoxide hydrolase ( EPHX2 ) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) studyHuman Molecular Genetics, 2006
- An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive HypertensionHypertension, 2005
- The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic strokeHuman Molecular Genetics, 2005
- Mechanism and signal transduction of 14 (R), 15 (S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytesProstaglandins & Other Lipid Mediators, 2000
- Cyclooxygenase-Derived Metabolites of 8,9-Epoxyeicosatrienoic Acid Are Potent Mitogens for Cultured Rat Glomerular Mesangial CellsBiochemical and Biophysical Research Communications, 1993